retatrutide liver damage Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety Fatty liver disease was alleviated

But look, I think its an interesting question and many may be aware of the fact they can go on ClinicalTrials.gov that there are now phase 3 registration trials that are been prepared and have now started in schizophrenia, in bipolar disorder, in major depressive disorder, beginning in opioid use disorder and alcohol use disorder with these drugs

Thats because Mounjaro has a dual-action that activates GIP & GLP-1 receptors agonist, often described at dual-hormone injection

In the retatrutide vs tirzepatide comparison, retatrutide appears more aggressive in early research, but tirzepatide currently has the advantage in regulatory approval, real-world availability, and longer safety follow-up

At present, the safety of the drug class in HFrEF needs to be further investigated (Khan et al., 2020)